Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

StrideBio
701 West Main Street, Suite 200
Durham, NC 27701
Phone: 302-290-5544
http://www.stridebio.com/

StrideBio, Inc is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies and therapeutics for rare diseases. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies and improving gene transfer efficiency in patients. This powerful new approach has broad application, enabling gene addition, gene silencing and gene editing modalities for a wide range of diseases, including rare genetic diseases.

Key Contact
Name
Patrick Ritschel
Title
President
Funding Events

Date
Amount
Type
Investors
Valuation
06/13/18 $15,700,000 Series A Alexandria Real Estate Equities
Hatteras Venture Partners
Takeda Ventures
UCB
undisclosed
03/16/21 $81,500,000 Series B Alexandria Venture Investments
CaaS Capital Management
Hatteras Venture Partners
Northpond Ventures
Novo Holdings
Octagon Capital
Pontifax
Sarepta Therapeutics
Takeda Ventures
UCB Ventures
UF Innovate Ventures
undisclosed


Featured Reading